Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

PHASE3CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Urogential Chlamydia Trachomatis Infection
Interventions
DRUG

Doxycyline Hyclate tablet

200 mg tablet, once daily for 7 days

DRUG

Vibramycin (doxycyline hyclate) capsule

100 mg capsule, twice daily for 7 days, over-encapsulated

Trial Locations (43)

11203

Research Site, Brooklyn

15025

Research Site, Jefferson Hills

19046

Research Site, Jenkintown

23507

Research Site, Norfolk

27405

Research Site, Greensboro

27612

Research Site, Raleigh

28562

Research Site, New Bern

29572

Research Site, Myrtle Beach

30033

Research Site, Decatur

31406

Research Site, Savannah

33063

Research Site, Margate

33143

Research Site, South Miami

33161

Research Site, North Miami

33401

Research Site, West Palm Beach

33432

Research Site, Boca Raton

33472

Research Site, Boynton Beach

35294

Research Site, Birmingham

36535

Research Site, Foley

39213

Research Site, Jackson

43231

Research Site, Columbus

46202

Research Site, Indianapolis

48201

Research Site, Detroit

60613

Research Site, Chicago

67005

Research Site, Arkansas City

67114

Research Site, Newton

67207

Research Site, Wichita

70072

Research Site, Marrero

70112

Research Site, New Orleans

70115

Research Site, New Orleans

73120

Research Site, Oklahoma City

77030

Research Site, Houston

78229

Research Site, San Antonio

85710

Research Site, Tucson

89030

Research Site, North Las Vegas

89106

Research Site, Las Vegas

89109

Research Site, Las Vegas

90007

Research Site, Los Angeles

92108

Research Site, San Diego

92805

Research Site, Anaheim

93726

Research Site, Fresno

98405

Research Site, Tacoma

99207

Research Site, Spokane

02720

Research Site, Fall River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT01113931 - Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin | Biotech Hunter | Biotech Hunter